Harbor Health Care ETF Rating $27.75 +0.56 (+2.06%) As of 08/15/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Harbor Health Care ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDI Aggregate RatingModerate Buy 2.88Holdings in MEDI have an aggregate rating of Moderate Buy based on 370 analyst ratings issued in the past year covering 24 companies (88.4% of the portfolio).MEDI Aggregate Price Target$27.75High Prediction$27.75Average Prediction$27.75Low Prediction$27.75Holdings in MEDI have an aggregate price target of $27.75 and a range of $27.75 to $27.75 covering 24 companies (88.4% of the portfolio).MEDI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Harbor Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 MEDI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.29%ASNDAscendis Pharma A/S$198.32+3.3%2.2228 of 5 stars3.00$242.93 22.5%1513.57%LLYEli Lilly and Company$701.51+2.5%4.9993 of 5 stars2.68$950.17 35.4%22Trending NewsAnalyst ForecastInsider TradeOptions VolumeAnalyst Revision5.60%UNHUnitedHealth Group$304.02+12.0%4.9584 of 5 stars2.50$366.52 20.6%24Trending NewsDividend AnnouncementOptions VolumeAnalyst RevisionGap UpHigh Trading Volume4.93%LEGNLegend Biotech$37.50-0.6%3.7348 of 5 stars3.00$72.38 93.0%10News CoverageEarnings ReportAnalyst Forecast4.79%MASIMasimo$153.87+1.3%4.3489 of 5 stars2.83$193.60 25.8%6Trending NewsAnalyst ForecastInsider Trade3.72%DXCMDexCom$80.95+1.2%4.828 of 5 stars2.95$99.89 23.4%22News CoveragePositive News3.39%ABBVAbbVie$206.65+1.0%4.7208 of 5 stars2.96$214.95 4.0%27Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.33%PCVXVaxcyte$32.70+4.0%2.1568 of 5 stars3.09$136.50 317.4%11News Coverage3.17%MRUSMerus$67.25+0.5%2.1001 of 5 stars3.09$88.50 31.6%112.62%DHRDanaher$210.84+0.3%4.7829 of 5 stars2.85$247.61 17.4%20News CoveragePositive NewsAnalyst Revision2.51%RYTMRhythm Pharmaceuticals$97.61+1.2%3.7525 of 5 stars3.07$101.57 4.1%15News CoverageInsider Trade2.39%SLNOSoleno Therapeutics$71.63-7.4%4.6117 of 5 stars3.09$113.30 58.2%11Gap DownHigh Trading Volume2.17%INSMInsmed$127.80+0.0%4.1092 of 5 stars2.94$129.57 1.4%16Trending NewsAnalyst ForecastAnalyst Revision2.14%ICLRIcon$175.84+0.3%4.3635 of 5 stars2.81$219.54 24.9%16Analyst Revision2.01%ISRGIntuitive Surgical$480.26+0.7%4.7019 of 5 stars2.63$595.95 24.1%19News CoveragePositive News1.82%PRCTPROCEPT BioRobotics$41.59+3.7%3.2704 of 5 stars2.78$74.88 80.0%9News CoverageGap Up1.77%WGSGeneDx$126.36+2.8%1.9615 of 5 stars2.75$101.63 -19.6%81.67%ALNYAlnylam Pharmaceuticals$448.91+1.4%4.243 of 5 stars2.85$405.33 -9.7%26Positive NewsInsider Trade1.57%NTRANatera$163.02+2.9%3.2358 of 5 stars3.06$193.19 18.5%18News CoverageAnalyst ForecastInsider Trade1.47%MLTXMoonLake Immunotherapeutics$54.39-0.9%2.7628 of 5 stars2.78$74.43 36.8%9Analyst Revision1.46%LNTHLantheus$54.18-0.5%4.7244 of 5 stars2.71$105.50 94.7%71.39%GEHCGE HealthCare Technologies$73.40-0.4%3.6843 of 5 stars2.73$88.55 20.6%11News CoveragePositive NewsShort Interest ↑1.37%HQYHealthEquity$89.89+2.8%4.3281 of 5 stars3.00$118.55 31.9%11News CoveragePositive News1.22%BSXBoston Scientific$103.15-1.0%4.7342 of 5 stars3.04$117.50 13.9%26Positive News This page (NYSEARCA:MEDI) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harbor Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Harbor Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access